Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMID 7019387)

Published in J Gen Microbiol on November 01, 1980

Authors

S W Shales, I Chopra, P R Ball

Articles citing this

Heterogeneity of tetracycline resistance determinants in Streptococcus. J Bacteriol (1982) 6.20

Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol Rev (1983) 5.45

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother (1999) 4.44

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother (1993) 3.13

Transposon Tn10 contains two structural genes with opposite polarity between tetA and IS10R. J Bacteriol (1984) 1.85

Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains. Antimicrob Agents Chemother (1982) 1.80

Characterization and expression of a cloned tetracycline resistance determinant from the chromosome of Streptococcus mutans. J Bacteriol (1984) 1.73

Multicopy Tn10 tet plasmids confer sensitivity to induction of tet gene expression. J Bacteriol (1983) 1.56

Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53

Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52

Tetracycline resistance transposon Tn1721: recA-dependent gene amplification and expression of tetracycline resistance. J Bacteriol (1981) 1.46

Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob Agents Chemother (1995) 1.38

Resistance to various tetracyclines mediated by transposon Tn10 in Escherichia coli K-12. Antimicrob Agents Chemother (1985) 1.03

Energetics of tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1984) 0.93

Dynamics of transcription driven by the tetA promoter, one event at a time, in live Escherichia coli cells. Nucleic Acids Res (2012) 0.92

Deletion of the multiple-drug efflux pump AcrAB in Escherichia coli prolongs the postantibiotic effect. Antimicrob Agents Chemother (2005) 0.85

Limitations of a fluorescence assay for studies on tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1983) 0.84

How to Measure Export via Bacterial Multidrug Resistance Efflux Pumps. MBio (2016) 0.78

Tetracycline-resistant L-forms isolated from an antibiotic-susceptible strain of Listeria monocytogenes. Antimicrob Agents Chemother (1982) 0.76

Articles by these authors

Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52

The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother (1981) 2.33

Genetic studies of a multi-resistant strain of Staphylococcus aureus. J Med Microbiol (1974) 2.19

Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun (1980) 1.98

Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92

Molecular basis of beta-lactamase induction in bacteria. Antimicrob Agents Chemother (1993) 1.89

A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85

Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol (1976) 1.81

Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol (1991) 1.78

Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72

Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69

Transport of antibiotics into bacteria. Adv Microb Physiol (1982) 1.62

Decreased uptake of cadmium by a resistant strain of Staphylococcus aureus. J Gen Microbiol (1970) 1.60

Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55

Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother (2006) 1.54

Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother (1992) 1.53

Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53

Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52

Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol (2007) 1.49

Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon. J Gen Microbiol (1981) 1.48

Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother (2007) 1.48

Tetracycline resistance transposon Tn1721: recA-dependent gene amplification and expression of tetracycline resistance. J Bacteriol (1981) 1.46

Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli. J Appl Bacteriol (1990) 1.41

Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40

Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother (2002) 1.33

Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33

RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (2000) 1.31

Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob Agents Chemother (2001) 1.31

Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29

Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25

Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20

Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother (2008) 1.20

Penicillin-binding protein 2 is required for induction of the Citrobacter freundii class I chromosomal beta-lactamase in Escherichia coli. Antimicrob Agents Chemother (1989) 1.20

Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol (1991) 1.17

Effect of plasmid carriage on the virulence of staphylococcus aureus. J Med Microbiol (1975) 1.16

Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob Agents Chemother (1992) 1.13

Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother (1994) 1.09

Induction of tetracycline resistance in Staphylococcus aureus in the absence of lipid synthesis. J Gen Microbiol (1975) 1.08

Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J Antimicrob Chemother (1986) 1.08

Towards new business models for R&D for novel antibiotics. Drug Resist Updat (2011) 1.08

SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrob Agents Chemother (1995) 1.07

Expression of the Staphylococcus aureus UDP-N-acetylmuramoyl- L-alanyl-D-glutamate:L-lysine ligase in Escherichia coli and effects on peptidoglycan biosynthesis and cell growth. J Bacteriol (1999) 1.07

Resistance to beta-lactams in Mycobacterium fortuitum. Antimicrob Agents Chemother (1992) 1.06

Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.06

Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus. J Gen Microbiol (1972) 1.05

Lysozyme-promoted association of protein I molecules in the outer membrane of Escherichia coli. J Bacteriol (1977) 1.05

High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis. J Antimicrob Chemother (2008) 1.05

Genetic analysis of the tetA(C) gene on plasmid pBR322. J Bacteriol (1992) 1.01

Particulate contaminants of intravenous medications and infusions. J Pharm Pharmacol (1987) 1.01

Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies. J Antimicrob Chemother (2007) 1.01

Mutations affecting penicillin-binding proteins 2a, 2b and 3 in Bacillus subtilis alter cell shape and peptidoglycan metabolism. J Gen Microbiol (1987) 0.98

The antibacterial effects of low concentrations of antibiotics. Adv Microb Physiol (1986) 0.98

Stabilization of Rhizobium symbiosis plasmids. Microbiology (1999) 0.97

Accumulation of tetracyclines by Escherichia coli K-12. Biochem Biophys Res Commun (1977) 0.97

Energetics of tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1984) 0.93

Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities. Antimicrob Agents Chemother (2001) 0.91

Biochemical and genetic characterization of the tet determinant of Bacillus plasmid pAB124. J Bacteriol (1984) 0.90

Inhibition of Escherichia coli K12 by short-chain organic acids: lack of evidence for induction of the SOS response. J Appl Bacteriol (1991) 0.88

Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ). J Antimicrob Chemother (2013) 0.87

Delayed postoperative intracerebral abscess caused by Proprionibacterium acnes: case report and review of the literature. Br J Neurosurg (2003) 0.87

Antibiotic resistance resulting from decreased drug accumulation. Br Med Bull (1984) 0.86

Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis. Mol Microbiol (1991) 0.86

Limitations of a fluorescence assay for studies on tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1983) 0.84

Uptake of tetracycline by Escherichia coli is not mediated by the sodium dependent glutamate transport system. J Antimicrob Chemother (1990) 0.83

Outer membrane composition in Escherichia coli and the poor activity of hydrophobic antibiotics against enteric bacteria. J Antimicrob Chemother (1982) 0.83

Mode of action of the cyclic depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic. J Antimicrob Chemother (1993) 0.83

Induction of the Citrobacter freundii group I beta-lactamase in Escherichia coli is not dependent on entry of beta-lactam into the cytoplasm. Antimicrob Agents Chemother (1990) 0.82

Use of mutator strains for characterization of novel antimicrobial agents. Antimicrob Agents Chemother (2001) 0.82

Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Mol Cell Endocrinol (1994) 0.81

Intradural metastatic spinal cord compression from ACTH-secreting pituitary carcinoma. Acta Neurochir (Wien) (2004) 0.81

Inhibition of beta-lactamase synthesis in Staphylococcus aureus by minocycline. J Antimicrob Chemother (1985) 0.80

Inhibition of Providencia stuartii cell envelope enzymes by chlorhexidine. J Antimicrob Chemother (1987) 0.80

Transcriptional signature following inhibition of early-stage cell wall biosynthesis in Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.80

Lack of correlation between methicillin resistance and susceptibility to lysostaphin in Staphylococcus aureus. J Gen Microbiol (1974) 0.79

Haemangioblastoma: a rare cause of a cerebellar mass in the elderly. Br J Neurosurg (2003) 0.79

Susceptibility of protein synthesis in Escherichia coli to tetracycline and minocycline. J Gen Microbiol (1981) 0.79

Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule. J Antimicrob Chemother (1986) 0.78

Genetic and biochemical basis of tetracycline resistance. J Antimicrob Chemother (1986) 0.78

Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections. Tuber Lung Dis (1998) 0.78

Rapid methods for testing the efficacy of sterilization-grade filter membranes. Appl Environ Microbiol (2000) 0.77

An assay to detect inhibitors of bacterial iron transport. J Antibiot (Tokyo) (1994) 0.77

Tetracycline resistance in Escherichia coli K12 is not associated with a decrease in cyclopropane fatty acid content. J Gen Microbiol (1977) 0.77

Plasmid-determined tetracycline resistance in Escherichia coli K12: lack of evidence that resistance is related to changes in lipid metabolism [proceedings]. Biochem Soc Trans (1978) 0.77

Inhibition of K88-mediated adhesion of Escherichia coli to mammalian receptors by antibiotics that affect bacterial protein synthesis. J Antimicrob Chemother (1986) 0.77

Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clin Endocrinol (Oxf) (1997) 0.76

Robust and sensitive nylon hybridization membrane suitable for high-throughput robotic arraying applications. Biotechniques (2002) 0.75

The significance of triiodothyronine. Calif Med (1973) 0.75

Pilocytic astrocytoma mimicking craniopharyngioma: a case series. Ann R Coll Surg Engl (2012) 0.75

Paradoxical response and tolerance in a strain of Staphylococcus aureus. J Antimicrob Chemother (1994) 0.75

Multiple isoelectric forms of bacterial penicillin-binding proteins: artefacts or genuine cellular components? J Antimicrob Chemother (1988) 0.75

Antibiotics and bacterial adhesion. J Antimicrob Chemother (1986) 0.75

Inhibition of K88ab-mediated haemagglutination by polymyxin B nonapeptide. J Antimicrob Chemother (1991) 0.75

Prediction of signal sequence-dependent protein translocation in bacteria: assessment of the Escherichia coli minicell system. Biochem Biophys Res Commun (1988) 0.75